British women who developed a form of cancer linked to their breast implants launch legal action

Linzy Bromfield, 50, (pictured) 'thought she was going to die' after she developed implant-associated lymphoma in 2016. She had the implants put in at a private clinic in the UK in 2005.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

We report a case of breast implant-associated anaplastic large cell lymphoma in a 70-year old woman, who 21 years previously had undergone bilateral breast augmentation with textured silicone implants. Eleven years later, she had bilateral implant removal with possible implant leak and presence of ‘atypical cells’ in the seroma. She then opted for prophylactic bilateral mastectomy in view of her strong family history of breast cancer and underwent reconstruction with subcutaneous gel implants. Eight months later, the patient noted right breast swelling and peri-implant effusion. The cytology was suspicious fo...
Source: Human Pathology: Case Reports - Category: Pathology Source Type: research
Two German companies have paired up on the development of a technology that could disrupt the breast implant market. BellaSeno will use Evonik's Resomer bioresorbable polymer in its Senella breast scaffolds with a proprietary additive manufacturing process that avoids the use of silicone implants, some of which have raised major safety concerns. BellaSeno plans to begin first-in-human clinical trials of the Senella scaffolds with Resomer in Germany this quarter. Evonik has agreed to supply its Resomer polymer for clinical and commercial use. The scaffolds are designed to guide the growth of natural tissue using the patient...
Source: MDDI - Category: Medical Devices Authors: Tags: 3-D Printing Source Type: news
AbstractPurpose of ReviewThe US Food and Drug Administration issued a recall of textured breast implants in July 2019 secondary to their association with anaplastic large cell lymphoma. This brief review serves to summarize what is actually known about breast implant associated anaplastic large cell lymphoma.Recent FindingsSince the FDA ’s first preliminary report in 2011, there have been a reported worldwide total of 573 breast implant associated anaplastic large cell lymphoma (BIA-ALCL) cases, including 33 deaths. In addition to halting the implantation of textured implants, the July recall served to increase aware...
Source: Current Breast Cancer Reports - Category: Cancer & Oncology Source Type: research
(CNN) — The US Food and Drug Administration on Wednesday released draft guidance recommending a “boxed warning” on labeling materials for breast implants. Boxed warnings, which alert health care providers and consumers to serious risks associated with a drug or device, are the strongest form of warning required by the FDA for labeling. An example of the boxed warning states that “breast implants are not considered lifetime devices” and “breast implants have been associated with the development of a cancer of the immune system called breast implant-associated anaplastic large cell lymphom...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Syndicated CBSN Boston breast implant illness CNN Source Type: news
Seminars in Plastic Surgery 2019; 33: 270-278 DOI: 10.1055/s-0039-1696998Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an emerging and indolent, but potentially fatal cancer of the immune system that can develop around textured-surface breast implants. The World Health Organization first recognized BIA-ALCL as a unique clinical entity in 2016. To date, over 600 confirmed cases have been reported worldwide. BIA-ALCL most commonly presents with disease confined to the capsule, as a seroma or a mass adjacent to the implant. While BIA-ALCL has a fairly indolent clinical course, with an excellent progno...
Source: Seminars in Plastic Surgery - Category: Cosmetic Surgery Authors: Tags: Review Article Source Type: research
Irene Kennedy, 49, from Leeds, found out she had breast implant-associated anaplastic large cell lymphoma in January. The cancer is linked to 'textured' silicone breast implants.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
A major producer of breast implants is stopping the sale and distribution of their textured products, amid growing links to a rare and deadly cancer. The FDA requested the recall from Allergan after a "significant increase" in cases of a particular lymphoma. The FDA says the risk of lymphoma with Allergan's Biocell textured implants is approximately six times that of other manufacturers who are marketing in the U.S. Anna Werner reports.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
A major producer of breast implants is stopping the sale and distribution of their textured products, amid growing links to a rare and deadly cancer. The FDA requested the recall from Allergan after a "significant increase" in cases of a particular lymphoma. The FDA says the risk of lymphoma with Allergan's Biocell textured implants is approximately six times that of other manufacturers who are marketing in the U.S. Anna Werner reports.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
The FDA says the textured surface, unique to Allergan’s implants, are tied to 481 cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma.
Source: WebMD Health - Category: Consumer Health News Source Type: news
FDA has finally drawn a line in the sand on an issue that has plagued the breast implant industry for years. On Wednesday the U.S. regulatory agency called on Allergan to take specific models of its textured breast implants off the market due to the risk of a rare type of cancer. "To protect individuals from the increased risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) associated with Allergan Biocell textured breast implants, [FDA] requested that Allergan recall its Biocell textured breast implants and tissue expanders," the agency said in a safety communicatio...
Source: MDDI - Category: Medical Devices Authors: Tags: Regulatory and Compliance Source Type: news
More News: Breast Augmentation | Cancer | Cancer & Oncology | Health | Legislation | Lymphoma | Plastic Surgery | UK Health | Women